In 2022, the Global Minimally Invasive Spine Surgery Market achieved a value of USD 2,679.8 million. Forecasts indicate a substantial growth trajectory, with expectations to reach USD 4,164.4 million by 2031, reflecting a projected Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period spanning from 2024 to 2031. 

Key trends in the minimally invasive spine surgery market reveal a surge in clinical trials, attributed to the increasing prevalence of spinal disorders and heightened research and development efforts. 

Unlike traditional spinal surgery, which often involves multiple incisions or muscle retraction, minimally invasive spinal procedures utilize smaller cameras and incisions. Statistics from a Texas Spine Center suggest a commendable success rate of over 90% for minimally invasive spine surgeries, albeit slightly lower than the 95% success rate associated with open spinal surgery. However, the consensus leans towards the superiority of minimally invasive techniques due to their manifold advantages. 

The market's expansion is further propelled by the myriad benefits it offers, coupled with a growing demand for spine treatments at the point of care. Notably, 

the North American regions are witnessing a surge in demand due to significant advancements and research in these domains. 

Competitive dynamics within the market, featuring major players such as Medtronic, Alliance Spine, and Stryker, among others, contribute to the escalating growth of the minimally invasive spine surgery market. This competitive landscape underscores ongoing efforts to innovate and enhance treatment options, further bolstering market expansion. 

For More Insights Request Free Sample: https://www.datamintelligence.com/download-sample/minimally-invasive-spine-surgery-market 

Market Segmentation 

By Product Type 

  • Instrumentation 

  • Devices 

By Application 

  • Non-fusion Surgery  

  • Fusion Surgery 

By End User 

  • Hospitals  

  • Ambulatory Surgical Centers 

  • Others 

Market Key Players 

Major players are Zimmer Biomet, DePuy Synthes (Johnson & Johnson), Stryker, Medtronic, Aesculap, Inc. (B. Braun Company), Alliance Spine, NuVasive Inc., Bioventus, Integra LifeSciences, and Globus Medical. 

 

Trending Reports